Your browser doesn't support javascript.
Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia.
Bellusci, Lorenza; Grubbs, Gabrielle; Srivastava, Pragya; Nemeth, Michael J; Griffiths, Elizabeth A; Golding, Hana; Khurana, Surender.
  • Bellusci L; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD; and.
  • Grubbs G; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD; and.
  • Srivastava P; Department of Medicine.
  • Nemeth MJ; Department of Immunology, and.
  • Griffiths EA; Department of Medicine.
  • Golding H; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD; and.
Blood ; 139(18): 2842-2846, 2022 05 05.
Article in English | MEDLINE | ID: covidwho-1765423

Full text: Available Collection: International databases Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Blood Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / COVID-19 Topics: Vaccines / Variants Limits: Humans Language: English Journal: Blood Year: 2022 Document Type: Article